Hussam A.S. Murad
Department of Pharmacology, Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
LiveDNA: 20.6304
Suleiman S. Al-Kayyal
Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia
Turky A. Alkaabi
Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia
PDF Fulltext XML References Citation
How to cite this article
Hussam A.S. Murad, Suleiman S. Al-Kayyal and Turky A. Alkaabi, 2021. Are the Newest Angiotensin Receptor Blockers Preferred than the Old Members in COVID-19 Patients with Cardiovascular Comorbidity?. International Journal of Pharmacology, 17: 435-441.
DOI: 10.3923/ijp.2021.435.441
URL: https://scialert.net/abstract/?doi=ijp.2021.435.441
DOI: 10.3923/ijp.2021.435.441
URL: https://scialert.net/abstract/?doi=ijp.2021.435.441